AR002727A1 - THE USE OF RIDOGREL FOR THE MANUFACTURE OF A MEDICATION USEFUL FOR THE TREATMENT OF DIGESTIVE INFLAMMATORY DISEASES, A PHARMACEUTICAL COMPOSITION INCLUDING RIDOGREL AND A PROCEDURE FOR PREPARING SUCH COMPOSITION. - Google Patents

THE USE OF RIDOGREL FOR THE MANUFACTURE OF A MEDICATION USEFUL FOR THE TREATMENT OF DIGESTIVE INFLAMMATORY DISEASES, A PHARMACEUTICAL COMPOSITION INCLUDING RIDOGREL AND A PROCEDURE FOR PREPARING SUCH COMPOSITION.

Info

Publication number
AR002727A1
AR002727A1 ARP960101944A AR10194496A AR002727A1 AR 002727 A1 AR002727 A1 AR 002727A1 AR P960101944 A ARP960101944 A AR P960101944A AR 10194496 A AR10194496 A AR 10194496A AR 002727 A1 AR002727 A1 AR 002727A1
Authority
AR
Argentina
Prior art keywords
ridogrel
preparing
manufacture
pharmaceutical composition
treatment
Prior art date
Application number
ARP960101944A
Other languages
Spanish (es)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR002727A1 publication Critical patent/AR002727A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

La presente invención se relaciona con el uso de ridogrel para la fabricación de un medicamento para el tratamiento de enfermedades digestivasinflamatorias, donde se administra ridogrel en una dosis diaria que oscila entre 0,01 mg/kg de peso corporal y 0,5 mg/kg de peso corporal; una composiciónfarmacéutica que comprende ridogrel y un procedimiento para preparar dicha composición farmacéutica.The present invention relates to the use of ridogrel for the manufacture of a drug for the treatment of inflammatory digestive diseases, where ridogrel is administered in a daily dose ranging from 0.01 mg / kg of body weight to 0.5 mg / kg of body weight; a pharmaceutical composition comprising ridogrel and a process for preparing said pharmaceutical composition.

ARP960101944A 1995-03-28 1996-03-27 THE USE OF RIDOGREL FOR THE MANUFACTURE OF A MEDICATION USEFUL FOR THE TREATMENT OF DIGESTIVE INFLAMMATORY DISEASES, A PHARMACEUTICAL COMPOSITION INCLUDING RIDOGREL AND A PROCEDURE FOR PREPARING SUCH COMPOSITION. AR002727A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95200768 1995-03-28

Publications (1)

Publication Number Publication Date
AR002727A1 true AR002727A1 (en) 1998-04-29

Family

ID=8220134

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960101944A AR002727A1 (en) 1995-03-28 1996-03-27 THE USE OF RIDOGREL FOR THE MANUFACTURE OF A MEDICATION USEFUL FOR THE TREATMENT OF DIGESTIVE INFLAMMATORY DISEASES, A PHARMACEUTICAL COMPOSITION INCLUDING RIDOGREL AND A PROCEDURE FOR PREPARING SUCH COMPOSITION.

Country Status (10)

Country Link
EP (1) EP0817631A2 (en)
JP (1) JPH10511097A (en)
AR (1) AR002727A1 (en)
AU (1) AU5397496A (en)
CA (1) CA2215160A1 (en)
HU (1) HUP9900309A3 (en)
IL (1) IL117670A (en)
NO (1) NO974486D0 (en)
WO (1) WO1996030016A2 (en)
ZA (1) ZA962461B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
EP1370244A1 (en) * 2001-03-12 2003-12-17 Novo Nordisk A/S Novel tablets and capsules and a process for its preparation
ITRM20050389A1 (en) 2005-07-22 2007-01-23 Giuliani Spa COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS.
UA107562C2 (en) 2008-12-05 2015-01-26 METHOD OF TREATMENT OF PSORIASIS
HUE032999T2 (en) 2009-02-16 2017-11-28 Nogra Pharma Ltd Alkylamido compounds and uses thereof
CN109999017A (en) 2012-02-09 2019-07-12 诺格拉制药有限公司 The method for treating fibrosis
CA2870490A1 (en) 2012-04-18 2013-10-24 Nogra Pharma Limited Methods of treating lactose intolerance
WO2017046343A1 (en) * 2015-09-17 2017-03-23 Nogra Pharma Limited Compositions for rectal administration in the treatment of ulcerative colitis and methods of using same
MX2021009498A (en) 2019-02-08 2021-09-08 Nogra Pharma Ltd Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746671A (en) * 1985-11-04 1988-05-24 Janssen Pharmaceutica N.V. Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters

Also Published As

Publication number Publication date
HUP9900309A2 (en) 1999-05-28
HUP9900309A3 (en) 1999-11-29
IL117670A (en) 2000-02-29
AU5397496A (en) 1996-10-16
MX9707394A (en) 1997-11-29
ZA962461B (en) 1997-09-29
NO974486L (en) 1997-09-29
NO974486D0 (en) 1997-09-29
IL117670A0 (en) 1996-07-23
CA2215160A1 (en) 1996-10-03
EP0817631A2 (en) 1998-01-14
JPH10511097A (en) 1998-10-27
WO1996030016A2 (en) 1996-10-03
WO1996030016A3 (en) 1997-01-30

Similar Documents

Publication Publication Date Title
CA2237306C (en) Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs
ES2178430T3 (en) USE OF GELIFICABLE PHARMACEUTICAL COMPOSITIONS IN PARODONTOLOGY.
CA2066403A1 (en) Transmucosal dosage form
RU94046316A (en) Use of high effective phosphonates for preparing medicinal agents for osteoporosis treatment
MX171191B (en) PHARMACEUTICAL COMPOSITIONS OF GLIPIZIDE
KR930702022A (en) Treatment or prevention of type 1 diabetes by oral administration of insulin
ES2188782T3 (en) PHARMACEUTICAL FORMULATIONS CONTAINING DARIFENACINE.
MX9400287A (en) PROCEDURE FOR THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF PARKINSON'S DISEASE
KR960700061A (en) PHARMACEUTICAL COMPOSITION FOR TREATING NICOTINE DEPENDENCE
KR970025615A (en) Cancer metastasis inhibitor
RU95101385A (en) Products containing g-csf and tnf-binding protein
AR002727A1 (en) THE USE OF RIDOGREL FOR THE MANUFACTURE OF A MEDICATION USEFUL FOR THE TREATMENT OF DIGESTIVE INFLAMMATORY DISEASES, A PHARMACEUTICAL COMPOSITION INCLUDING RIDOGREL AND A PROCEDURE FOR PREPARING SUCH COMPOSITION.
KR830002510A (en) Composition consisting of biologically active compound and hydroxyalkyl starch
AR035946A1 (en) PHARMACEUTICAL COMPOSITIONS TO USE IN THE TREATMENT OF DISORDERS IN WOMEN PERIMENOPAUSIC, MENOPAUSIC OR POSMENOPAUSIC, AND USES OF SUCH COMPOSITIONS FOR THE PREPARATION OF MEDICINES
TR200101163T2 (en) Bile water substituted phenyl-alkenoylguanidines, production methods, uses
KR0178762B1 (en) New medical use for a certain indole derivative and pharmaceutical composition containing it
AR006202A1 (en) USES OF IGE ANTAGONIST TO PREPARE A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF ALLERGIC DISEASES AND COMPOSITIONS CONTAINING THEM
BR0107881A (en) Fsh use infertility treatment
ATE91890T1 (en) MANUFACTURE OF A DRUG AGAINST ARTHRITIS AND RHEUMATISM.
BE1002256A3 (en) DRUGS.
NZ207411A (en) Pharmaceutical compositions containing paracetamol and tizanidine
JPS59116219A (en) Novel medicine mixture containing combination of central analgesic and vitamin b 12 or derivative as active component
KR910007528A (en) Use of Benzodiazepines and Phenylpyrylketone Derivatives
GB2135884A (en) Analgesic preparations containing tizanidine and paracetamol
KR950700063A (en) Brofaromine as an agent for treating post-traumatic stress